Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 8
1986 9
1987 6
1988 6
1989 3
1990 14
1991 13
1992 10
1993 4
1994 12
1995 13
1996 11
1997 10
1998 10
1999 11
2000 15
2001 14
2002 15
2003 12
2004 7
2005 8
2006 5
2007 16
2008 8
2009 7
2010 7
2011 10
2012 9
2013 10
2014 13
2015 14
2016 8
2017 14
2018 6
2019 7
2020 5
2021 11
2022 10
2023 6
2024 2
2025 3
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

357 results

Results by year

Filters applied: . Clear all
Page 1
Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D'Egidio A, D'Ippoliti F, Raffone C, Venditti M, Guarracino F, Girardis M, Tritapepe L, Pietropaoli P, Mebazaa A, Singer M. Morelli A, et al. JAMA. 2013 Oct 23;310(16):1683-91. doi: 10.1001/jama.2013.278477. JAMA. 2013. PMID: 24108526 Clinical Trial.
For stroke volume index, the median AUC for esmolol was 4 mL/m2 (IQR, -1 to 10) vs 1 mL/m2 for the control group (IQR, -3 to 5; P = .02), whereas the left ventricular stroke work index for esmolol was 3 mL/m2 (IQR, 0 to 8) vs 1 mL/m2 for the control group (IQR, -2 t …
For stroke volume index, the median AUC for esmolol was 4 mL/m2 (IQR, -1 to 10) vs 1 mL/m2 for the control group (IQR, -3 to 5; P = . …
Intra-operative esmolol and pain following mastectomy: A randomised clinical trial.
Mendonça FT, Tramontini AJ, Miake HI, Seixas LF, de Carvalho LSF, Sposito AC. Mendonça FT, et al. Eur J Anaesthesiol. 2021 Jul 1;38(7):735-743. doi: 10.1097/EJA.0000000000001512. Eur J Anaesthesiol. 2021. PMID: 33831899 Clinical Trial.
BACKGROUND: Esmolol is a beta-1 selective blocker that has been shown to reduce postoperative pain. ...The length of hospital stay was shorter for the esmolol group (mean difference = -6.9 h, 95% CI, -13.4 to -0.31, P = 0.040). CONCLUSION: Esmolol was well to …
BACKGROUND: Esmolol is a beta-1 selective blocker that has been shown to reduce postoperative pain. ...The length of hospital stay wa …
Prospective Clinical Trial Comparing IV Esmolol to IV Metoprolol in CT Coronary Angiography: Effect on Hemodynamic, Technical Parameters and Cost.
Vimala LR, Eifer DA, Karimzad Y, Paul NS. Vimala LR, et al. Can Assoc Radiol J. 2022 Feb;73(1):240-248. doi: 10.1177/08465371211023947. Epub 2021 Jul 22. Can Assoc Radiol J. 2022. PMID: 34293933 Free article. Clinical Trial.
The primary aim was to prospectively compare IV esmolol alone to IV metoprolol alone for effectiveness in achieving heart rate [HR] of 60 beats per minute[bpm] during CCTA. ...CONCLUSION: Comparison of IV esmolol and IV metoprolol demonstrate that both are effective …
The primary aim was to prospectively compare IV esmolol alone to IV metoprolol alone for effectiveness in achieving heart rate [HR] o …
Effects of dexmedetomidine and esmolol on otoacoustic emissions during controlled hypotensive anesthesia: randomized clinical trial.
Gökahmetoğlu G, Pehlivan S, Aksu R, Biçer C. Gökahmetoğlu G, et al. Clin Invest Med. 2020 Apr 5;43(1):E9-E17. doi: 10.25011/cim.v43i1.33564. Clin Invest Med. 2020. PMID: 32247297 Clinical Trial.
PURPOSE: The aim of this study was to investigate the ability of esmolol and dexmedetomidine to achieve controlled hypotension on cochlea by measuring otoacoustic emission and stapedius reflex. ...CONCLUSIONS: Infusion of dexmedetomidine and esmolol decreased DPOAE …
PURPOSE: The aim of this study was to investigate the ability of esmolol and dexmedetomidine to achieve controlled hypotension on coc …
Effects of lidocaine and esmolol on hemodynamic response to tracheal intubation: a randomized clinical trial.
Mendonça FT, Silva SLD, Nilton TM, Alves IRR. Mendonça FT, et al. Braz J Anesthesiol. 2022 Jan-Feb;72(1):95-102. doi: 10.1016/j.bjane.2021.01.014. Epub 2021 Sep 25. Braz J Anesthesiol. 2022. PMID: 34582903 Free PMC article. Clinical Trial.
This study aimed to compare the beta-blocker esmolol with lidocaine regarding the effects on hemodynamic response after orotracheal intubation. ...Participants were randomly allocated to receive 1.5 mg.kg(-1) esmolol bolus followed by 0.1 mg.kg(-1).min(-1) esmolo …
This study aimed to compare the beta-blocker esmolol with lidocaine regarding the effects on hemodynamic response after orotracheal i …
Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial.
Rastogi A, Kulkarni SA, Agarwal S, Akhtar M, Arsule S, Bhamre S, Bhosle D, Desai S, Deshmukh M, Giriraja KV, Jagannath J, Kashiva RY, Kesavan R, Khandelwal D, Kolte S, Kongara S, Darivemula AK, Madhusudan C, Pyare Saheb Qureshi MAH, Ramu M, Rathod G, Yalamanchi SR, Shakya S, Shetty P, Singh S, Deshpande SK, Viswanathan V, Unnikrishnan AG. Rastogi A, et al. JAMA Netw Open. 2023 May 1;6(5):e2311509. doi: 10.1001/jamanetworkopen.2023.11509. JAMA Netw Open. 2023. PMID: 37184839 Free PMC article. Clinical Trial.
The median time for ulcer closure was 85 days for the esmolol with SoC group and was not estimable for SoC only group. Significant benefits of Esmolol with SoC were seen in patients with factors that impede the healing of DFU. ...CONCLUSIONS AND RELEVANCE: In this m …
The median time for ulcer closure was 85 days for the esmolol with SoC group and was not estimable for SoC only group. Significant be …
Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial.
Abrams J, Allen J, Allin D, Anderson J, Anderson S, Blanski L, Chadda K, DiBianco R, Favrot L, Gonzalez J, et al. Abrams J, et al. Am Heart J. 1985 Nov;110(5):913-22. doi: 10.1016/0002-8703(85)90185-1. Am Heart J. 1985. PMID: 3904379 Clinical Trial.
The principal adverse effect was hypotension, reported in 23 esmolol (asymptomatic in 19) and four propranolol (asymptomatic in three) patients. In the majority of esmolol patients, hypotension resolved quickly (within 30 minutes) after esmolol was discontinu …
The principal adverse effect was hypotension, reported in 23 esmolol (asymptomatic in 19) and four propranolol (asymptomatic in three …
Esmolol in Cardiac Surgery: A Randomized Controlled Trial.
Zangrillo A, Bignami E, Noè B, Nardelli P, Licheri M, Gerli C, Crivellari M, Oriani A, Di Prima AL, Fominskiy E, Di Tomasso N, Lembo R, Landoni G, Crescenzi G, Monaco F. Zangrillo A, et al. J Cardiothorac Vasc Anesth. 2021 Apr;35(4):1106-1114. doi: 10.1053/j.jvca.2020.12.029. Epub 2021 Jan 13. J Cardiothorac Vasc Anesth. 2021. PMID: 33451954 Clinical Trial.
OBJECTIVE: To assess whether the administration of the ultra-short-acting beta-blocker esmolol in cardiac surgery could have a cardioprotective effect that translates into improved postoperative outcomes. ...INTERVENTIONS: Patients were assigned randomly to receive either …
OBJECTIVE: To assess whether the administration of the ultra-short-acting beta-blocker esmolol in cardiac surgery could have a cardio …
The effects of remifentanil and esmolol on increase in intraocular pressure due to laryngoscopy and tracheal intubation: a double-blind, randomized clinical trial.
Tuzcu K, Tuzcu EA, Karcioglu M, Davarci I, Coskun M, Ilhan O, Daglıoglu MC, Turhanoglu S. Tuzcu K, et al. J Glaucoma. 2015 Jun-Jul;24(5):372-6. doi: 10.1097/IJG.0b013e31829f9bfe. J Glaucoma. 2015. PMID: 23835673 Clinical Trial.
The patients were randomized into 2 groups by using the sealed-envelope method, as follows: group E (esmolol) and group R (remifentanil). A single intravenous dose of esmolol (0.5 mg/kg) or remifentanil (1 mug/kg) just before induction agents were given to patients …
The patients were randomized into 2 groups by using the sealed-envelope method, as follows: group E (esmolol) and group R (remifentan …
Clinical pharmacology, pharmacodynamics and interactions with esmolol.
Lowenthal DT, Porter RS, Saris SD, Bies CM, Slegowski MB, Staudacher A. Lowenthal DT, et al. Am J Cardiol. 1985 Oct 23;56(11):14F-18F. doi: 10.1016/0002-9149(85)90911-7. Am J Cardiol. 1985. PMID: 2864843 Clinical Trial.
The clinical pharmacology and pharmacodynamic data from several clinical trials are summarized. The pharmacokinetic profile of esmolol alone and in the presence of digoxin, morphine and warfarin was studied. Conversely the effect of esmolol on these drugs was monito …
The clinical pharmacology and pharmacodynamic data from several clinical trials are summarized. The pharmacokinetic profile of esmolol …
357 results